» Articles » PMID: 33536908

Targets and Mechanism Used by Cinnamaldehyde, the Main Active Ingredient in Cinnamon, in the Treatment of Breast Cancer

Overview
Journal Front Pharmacol
Date 2021 Feb 4
PMID 33536908
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer has become one of the most common malignant tumors in women owing to its increasing incidence each year. Clinical studies have shown that (L.) (cinnamon) has a positive influence on the prevention and treatment of breast cancer. We aimed to screen the potential targets of cinnamon in the treatment of breast cancer through network pharmacology and explore its potential therapeutic mechanism through cell experiments. We used the TCMSP, TCM Database @ Taiwan, and TCMID websites and established the active ingredient and target database of cinnamon. Thereafter, we used the GeneCards and OMIM databases to establish a breast cancer-related target database, which matched the cinnamon target database. Based on the matching results, the STRING database was used to analyze the interaction between the targets, and the biological information annotation database was used to analyze the biological process of the target (gene ontology) and the pathway enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG). After establishing the layout of the analysis, we used Cytoscape 3.6.0 software for network analysis. Finally, the cell experiment was used to verify the anti-breast cancer effect of cinnamaldehyde. Our research showed that the main components of cinnamon, including cinnamaldehyde, can play a role in the treatment of breast cancer through 59 possible important targets. Subsequently, enrichment analysis by gene ontology and Kyoto Encyclopedia of Genes and Genomes showed that 83 cell biological processes and 37 pathways were associated with breast cancer ( < 0.05), including the peroxisome proliferator-activated receptor and PI3K-Akt pathway, which are closely related to tumor cell apoptosis. cell verification experiments showed that cinnamaldehyde can significantly inhibit cell proliferation, change cell morphology, inhibit cell migration and invasion ability, and promote cell apoptosis. Our results showed that cinnamaldehyde is a potential novel drug for the treatment and prevention of breast cancer.

Citing Articles

A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors.

Rampogu S, Al-Antari M, Oh T, Shaik B Mol Biol Rep. 2025; 52(1):203.

PMID: 39907697 DOI: 10.1007/s11033-025-10300-0.


Exploration of compatibility rules and discovery of active ingredients in TCM formulas by network pharmacology.

Liu Y, Li X, Chen C, Ding N, Ma S, Yang M Chin Herb Med. 2024; 16(4):572-588.

PMID: 39606260 PMC: 11589340. DOI: 10.1016/j.chmed.2023.09.008.


Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial.

Moreira F, Reis C, Gallassi A, Moreira D, Welker A PLoS One. 2024; 19(10):e0311501.

PMID: 39383145 PMC: 11463819. DOI: 10.1371/journal.pone.0311501.


6-Gingerol modulates miRNAs and PODXL gene expression via methyltransferase enzymes in NB4 cells: an in silico and in vitro study.

Afgar A, Ramezani Zadeh Kermani M, Pabarja A, Afgar A, Kavyani B, Arezoomand H Sci Rep. 2024; 14(1):18356.

PMID: 39112503 PMC: 11306743. DOI: 10.1038/s41598-024-68069-4.


Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review).

Han R, Li X, Gao X, Lv G Mol Med Rep. 2024; 30(3).

PMID: 38994757 PMC: 11267250. DOI: 10.3892/mmr.2024.13287.


References
1.
Wu C, Zhuang Y, Zhou J, Liu S, Wang R, Shu P . Cinnamaldehyde enhances apoptotic effect of oxaliplatin and reverses epithelial-mesenchymal transition and stemnness in hypoxic colorectal cancer cells. Exp Cell Res. 2019; 383(1):111500. DOI: 10.1016/j.yexcr.2019.111500. View

2.
Cai M, Liang X, Sun X, Chen H, Dong Y, Wu L . Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway. Front Oncol. 2019; 9:164. PMC: 6434718. DOI: 10.3389/fonc.2019.00164. View

3.
Cabello C, Bair 3rd W, Lamore S, Ley S, Bause A, Azimian S . The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med. 2008; 46(2):220-31. PMC: 2650023. DOI: 10.1016/j.freeradbiomed.2008.10.025. View

4.
Ng L, Wu S . Antiproliferative Activity of Cinnamomum cassia Constituents and Effects of Pifithrin-Alpha on Their Apoptotic Signaling Pathways in Hep G2 Cells. Evid Based Complement Alternat Med. 2009; 2011:492148. PMC: 3135661. DOI: 10.1093/ecam/nep220. View

5.
Kaur G, Athar M, Alam M . Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog. 2010; 49(3):290-301. DOI: 10.1002/mc.20601. View